BREAKING
Home » Archive by Category "Drugs and antibiotics" (Page 2)

Phase 2/3 clinical trial for critically ill COVID-19 patients continues to enroll patients as cases surge across the country

By

NeuroRx, Inc., in partnership with RELIEF THERAPEUTICS Holdings AG today announced that the independent Data Monitoring Committee has reviewed the findings in the first 30 patients treated in Fast Track...

Tocilizumab linked to 45% lower risk of dying among critically ill COVID-19 patients

By

Critically ill COVID-19 patients who received a single dose of a drug that calms an overreacting immune system were 45% less likely to die overall, and more likely to be out of the hospital or off a ventilator...

Antibiotic recalled: One lot of Mylan’s Daptomycin for Injection, Presence of particulate matter found

By

Mylan N.V.External Link Disclaimer  announced Tuesday that its U.S.-based Mylan Institutional LLC business is conducting a voluntary nationwide recall to the consumer level of one lot of Daptomycin for...

Henry Ford Hospital researchers: Treatment with Hydroxychloroquine cut death rate significantly in COVID-19 patients

By

Treatment with hydroxychloroquine cut the death rate significantly in sick patients hospitalized with COVID-19 – and without heart-related side-effects, according to a new study published by Henry...

Fast Track Designation of RLF-100 for the treatment of Acute Lung Injury/Acute Respiratory Distress Syndrome associated with COVID-19

By

NeuroRx, Inc., in partnership with RELIEF THERAPEUTICS Holding AG today announced that the U.S. Food and Drug Administration (FDA) awarded Fast Track Designation to NeuroRx for the investigation of RLF-100...

Swimmer’s ear: ALK gains exclusive rights to market OTIPRIO in U.S.

By

ALK, a global, research-driven pharmaceutical company that focuses on the prevention, diagnosis and treatment of allergies, announced today the signing of an exclusive agreement with Otonomy, a biopharmaceutical...

Baricitinib Phase 3 Clinical Trial begins: For hospitalized COVID-19 patients

By

Eli Lilly and Company announced today that the first patient has been enrolled in a Phase 3 randomized, double-blind, placebo–controlled study to evaluate the efficacy and safety of baricitinib, an oral...

COVID-19

COVID-19: Investigational dual antibody cocktail, REGN-COV2, clinical trial initiated

By

Regeneron Pharmaceuticals, Inc. today announced initiation of the first clinical trial of REGN-COV2, its investigational dual antibody cocktail for the prevention and treatment of COVID-19. The REGN-COV2...

TB drug, rifabutin, active against Acinetobacter baumannii in the lab

By

USC researchers have discovered that an old antibiotic may be a powerful new tool against a deadly superbug, thanks to an innovative screening method that better mimics conditions inside the human body. The...

Cytokine storm: Acalabrutinib assists in calming down in COVID-19 patients in study

By

The drug acalabrutinib, FDA-approved for the treatment of several types of B cell cancers, improved the oxygenation levels and decreased molecular markers of inflammation in a majority of 19 patients hospitalized...